
Biocon Itolizumab Updates
The drug has recently gathered criticism regarding phase 2 clinical trial that enrolled 31 patients…
The drug has recently gathered criticism regarding phase 2 clinical trial that enrolled 31 patients…
Cipla Ltd (SHARE PRICE) has priced its generic version of remdesivir, Cipremi, at 4,000 rupees…
In a 60-minute interview to Karan Thapar for The Wire, Dr Raman Gangakhedkar, retired Head of…
Bharat Biotech has successfully developed COVAXIN™, India’s 1st vaccine candidate for COVID-19, in collaboration with…
The Central government has approved the use of low-cost steroid medicine dexamethasone for the treatment…
On July 02, the Uttarakhand High Court issued notices to yoga guru Ramdev’s Patanjali, Union…
Against the backdrop of leading vaccine maker Bharat Biotech partnering with Thomas Jefferson University of…
PerkinElmer has announced that PerkinElmer India has received commercial approval from the Central Drugs Standard…
A new Covid-19 test developed by the Centre for Cellular and Molecular Biology (CCMB) can…
Excelra, a leading global data-analytics company today announced the release of the COVID-19 Biomarker Database…